title: Therapeutic monitoring of psychotropic drugs: an outline of the AGNP-TDM expert group consensus guideline.
abstract: TDM of psychotropic drugs is widely used, but there is little consensus regarding its optimal use in the clinical context. This prompted a multidisciplinary group comprised of clinical biochemists, clinical pharmacologists, and psychiatrists of the AGNP (Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie) to provide a consensus guideline. This will allow clinical psychiatrists, practitioners, and laboratory directors involved in psychopharmacotherapy to optimize TDM of antidepressants, antipsychotics, and opioid substituents. Recommendations are also given on the combined use of TDM and pharmacogenetic tests.
authors.affiliation: Unité de Biochimie et Psychopharmacologie Clinique, Département Universitaire de Psychiatrie Adulte, CH-1008 Prilly-Lausanne, Switzerland. pierre.baumann@inst.hospvd.ch
authors.forename: P
authors.initials: P
authors.lastname: Baumann
authors.forename: C
authors.initials: C
authors.lastname: Hiemke
authors.forename: S
authors.initials: S
authors.lastname: Ulrich
authors.forename: I
authors.initials: I
authors.lastname: Gaertner
authors.forename: M L
authors.initials: ML
authors.lastname: Rao
authors.forename: G
authors.initials: G
authors.lastname: Eckermann
authors.forename: M
authors.initials: M
authors.lastname: Gerlach
authors.forename: H J
authors.initials: HJ
authors.lastname: Kuss
authors.forename: G
authors.initials: G
authors.lastname: Laux
authors.forename: B
authors.initials: B
authors.lastname: Müller-Oerlinghausen
authors.forename: P
authors.initials: P
authors.lastname: Riederer
authors.forename: G
authors.initials: G
authors.lastname: Zernig
mesh_terms: D016903:Drug Monitoring / Q000379:methods / Q000592:standards*; D006801:Humans; D017410:Practice Guidelines as Topic; D011619:Psychotropic Drugs / Q000097:blood* / Q000627:therapeutic use; D012016:Reference Values
chemical_list: D011619:Psychotropic Drugs